AI Article Synopsis
- Streptococcus agalactiae (GBS) is a major cause of illness and death in newborns, leading to the recommendation that all pregnant women be screened for GBS colonization between 34 and 37 weeks of gestation.
- The study highlights the importance of accurate and timely microbiological diagnostics for GBS screening in pregnant women.
- Over six years, the carriage rate of GBS in newborns remained consistently around 13 to 14%, indicating stable colonization levels throughout the study.
Article Abstract
Streptococcus agalactiae (GBS) is a significant cause of morbidity and mortality among newborns. Colonization frequently occurs in pregnant women, nearly all international recommendations suggest that all pregnant women must be screened for vaginal colonization at 34 to 37 weeks of gestation. The microbiological diagnostic modalities used to combat GBS had to be accurate and in short time frame. We reported a 6 years experience of GBS screening, comparing results of culture swab of prenatal vaginal specimens and newborns colonization or infection. The carriage rate of 13 to 14% of GBS in newborn was unchanged during all the study period.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.patbio.2009.07.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!